Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small ...

Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from ...

The biggest bottleneck slowing progress in drug development is the competition for, and successful recruitment of, patients for participation in clinical trials, while also ensuring participants ...

I have always loved science, but I originally expected to stay in academic research. I studied in the UK, completing my PhD at Durham University. During my PhD, the Stem Cell Network in Canada reached ...

From analytical data management to automated structure verification, explore practical approaches to digitalization and AI in pharmaceutical R&D. Digitalization and AI initiatives depend on accessible ...

The year 2026 is anticipated to mark a significant transformation in life sciences, driven by the integration of Agentic AI into clinical research and biopharma. This shift aims to alleviate ...

We are all watching the rise of oral, small molecule GLP-1 receptor agonists with justified interest. The promising phase III results of Eli Lilly’s orforglipron has set the pace, and others are ...

China’s rise in biopharma is often framed as a competitive challenge to the West. For Lingshi Tan, Executive Chairman of Caidya, that framing misses the larger point: drug development itself is ...

Caribou Biosciences plans to discontinue its two allogeneic CAR T-cell therapy programs and make substantial workforce reductions after struggling to secure the funding needed to continue their ...

Earlier this year, Lonza entered into a strategic collaboration with Germany-based biotech Ethris to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates designed ...

Vyriad has begun a phase I trial of VV169, an off-the-shelf lentiviral therapy designed to generate BCMA-targeted CAR T cells directly inside the body. The first-in-human study is recruiting patients ...

Welcome to our annual showcase of top technology launches this year for drug development and manufacturing! Every year, The Medicine Maker asks readers to submit their nominations for inspiring ...